相关实验视频
Updated: May 6, 2026

13:08
Creation and Maintenance of a Living Biobank - How We Do It
Published on: April 10, 2021
7.6K
用于转化研究和精准医学的患者衍生器官生物库:挑战和未来前景
Floriana Jessica Di Paola1, Giulia Calafato1, Pier Paolo Piccaluga1
1Biobank of Research, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.
Journal of personalized medicine
|August 27, 2025
概括
患者产生的有机物 (PDO) 正在彻底改变癌症研究和精确医学. 活着的PDO生物库为药物查和生物标志物发现提供了重要平台,促进了个性化癌症护理.
科学领域:
- 生物医学工程
- 癌症学
- 翻译医学
背景情况:
- 患者衍生器官 (PDO) 非常接近父母瘤的特征.
- 活着的PDO生物库对于药物查和生物标志物发现至关重要.
- 在癌症研究和精准医学方面,
研究的目的:
- 审查瘤和健康组织特异性PDO生物库的分类和全球分布.
- 探索PDO生物库的转化应用.
- 讨论将PDO生物库纳入临床实践的挑战和未来方向.
主要方法:
- 对原名生物库的现有文献进行审查.
- 生物库的PDO分类和全球分布的分析.
- 讨论有机体培养系统和媒介的进展.
主要成果:
- 全球越来越多地建立了PDO生物库,支持各种研究应用.
- 标准化工作和可访问性正在增加.
- 最近的培养系统的进步旨在提高长期生存能力,并模仿瘤的微环境.
结论:
- 生物库是个性化医学和癌症研究的重要工具.
- 克服培养和维护方面的技术挑战是临床整合的关键.
- 未来的努力应集中在标准化,可访问性和临床翻译上.
相关概念视频
Issues And Trends In Healthcare Delivery System
6.5K
The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
6.5K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
631
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
631
Bioavailability Study Design: Healthy Subjects Versus Patients
252
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
252
Bioequivalence studies: Biowaivers
433
In certain scenarios, in vitro dissolution tests can replace in vivo bioequivalence studies. This is particularly true when a drug product, though available in varying strengths, maintains proportional similarity in its active and inactive ingredients. In such cases, the need for in vivo bioequivalence studies for lower strength variants may be waived, provided dissolution tests and in vivo studies on the highest strength yield satisfactory results.Bioequivalence can be indicated through...
433
Pharmacogenomics: Identification of New Drug Targets
129
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
129

